Abstract 4591: Estrogen receptor-positive breast cancer: from genomic landscape to treatment approach
Pradip De(University of South Dakota), Brian Leyland‐Jones(Avera Health), Casey Williams(Creighton University), Kirstin Williams(Avera Health), Jennifer Carlson(Avera Health), Nandini Dey(University of South Dakota), Jessica Klein(Cancer Institute (WIA)), Amy Krie(Amgen (United States))
Cited by 1
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
RET rearrangements are actionable alterations in breast cancer
|Nature Communications|2018|127